Fundraising Fox

venBio Global Strategic

San Francisco

Fox Verdict
Sign up to see your fit

Fund manager profile

venBio Global Strategic is a venture fund manager based in San Francisco. SEC filings show 4 venture funds on record, most recently venBio Global Strategic Fund V, L.P. filed July 2024.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
San Francisco, US

What they invest in

from 5 of 0 portfolio companies

Biotech ×4Healthtech ×1

HQs:United States×20

Board seats · per SEC filings · 20

what is this? ⓘ
Entact Bio, Inc.SEC filing

$10M raise · filed Jun 2026 · via Richard Gaster

Caldera Therapeutics, Inc.SEC filing

$37.5M raise · filed Jan 2026 · via Aaron Royston

Aeovian Pharmaceuticals, Inc.SEC filing

$55M raise · filed Dec 2025 · via Richard C. Gaster, Richard J. Gaster

Arpeggio Biosciences, Inc.SEC filing

$35.3M raise · filed Nov 2025 · via Aaron G. Royston

Eyconis, Inc.SEC filing

$89.8M raise · filed Oct 2025 · via Yvonne Moller Yamanaka, Yvonne Yamanaka

Axonis TherapeuticsSEC filing

$115M raise · filed Nov 2024 · via Corey . Goodman

Marea Therapeutics, Inc.SEC filing

$160.4M raise · filed Jun 2024 · via Aaron Royston

ImmPACT Bio USA Inc.SEC filing

$141.8M raise · filed Apr 2024 · via Yvonne Yamanaka

ALUMIS INC.SEC filing

$259M raise · filed Mar 2024 · via Richard Gaster

Attralus, Inc.SEC filing

$56M raise · filed Feb 2024 · via Corey Goodman, Richard Gaster

INSAMO INC.SEC filing

$2.3M raise · filed Dec 2023 · via Corey Goodman

NFlection Therapeutics, Inc.SEC filing

$4M raise · filed Jul 2023 · via Corey Goodman

FOG PharmaceuticalsSEC filing

$178M raise · filed Dec 2022 · via Corey S. Goodman

RayzeBio, Inc.SEC filing

$167.9M raise · filed Sep 2022 · via Aaron Royston

Ventyx Biosciences, Inc.SEC filing

$51M raise · filed Sep 2021 · via Aaron W. Royston, Richard W. Gaster

Swift Health Systems Inc.SEC filing

$112M raise · filed Sep 2021 · via Aaron J Royston

Tallac Therapeutics, Inc.SEC filing

$61.6M raise · filed Jul 2021 · via Corey Goodman

Neurogastrx, Inc.SEC filing

Raise · filed Jul 2021 · via Aaron Royston

Artiva Biotherapeutics, Inc.SEC filing

$120M raise · filed Apr 2021 · via Yvonne J. Yamanaka

Impel NeuropharmaSEC filing

$1.9M raise · filed Apr 2021 · via Aaron D. Royston

Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Frequently asked questions

Where is venBio Global Strategic located?
venBio Global Strategic is headquartered in San Francisco, US.

Featured in lists